517 results on '"Norman, Gary L."'
Search Results
2. Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study
3. Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected coeliac disease without IgA deficiency (Bi.A.CeD): a multicentre, prospective cohort study
4. Anti-HMGCR myopathy overlaps with dermatomyositis-like rash: a distinct subtype of idiopathic inflammatory myopathy
5. Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG
6. Calprotectin Impairs Platelet Survival in Patients With Primary Antiphospholipid Syndrome
7. Anti-β2GPI domain 1 antibodies stratify high risk of thrombosis and late pregnancy morbidity in a large cohort of Chinese patients with antiphospholipid syndrome
8. KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis
9. Anti‐kelch‐like 12 and anti‐hexokinase 1: novel autoantibodies in primary biliary cirrhosis
10. Contributors
11. The evolving potential of precision medicine in the management of autoimmune liver disease
12. Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome
13. Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study
14. Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected coeliac disease without IgA deficiency (Bi.A.CeD): a multicentre, prospective cohort study
15. COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis
16. Comprehensive review of autoantibodies in patients with hyper-IgM syndrome
17. Autoimmune gastritis serological biomarkers in gastric cancer patients
18. Activity of Sera from Patients with Lyme Disease against Borrelia burgdorferi
19. Significance of fully automated tests for the diagnosis of antiphospholipid syndrome
20. “Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort
21. Autoimmune gastritis serological biomarkers in gastric cancer patients.
22. Prevalence of Antiphospholipid Antibodies and Association With Incident Cardiovascular Events
23. Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA
24. Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis
25. The Diagnostic Value of Anti-Parietal Cell and Intrinsic Factor Antibodies, Pepsinogens, and Gastrin-17 in Corpus-Restricted Atrophic Gastritis
26. PR3-ANCA: A promising biomarker for ulcerative colitis with extensive disease
27. Short article: Absence of serological rheumatoid arthritis biomarkers in inflammatory bowel disease patients with arthropathies
28. Autoantibodies to domain 1 of beta 2 glycoprotein 1: A promising candidate biomarker for risk management in antiphospholipid syndrome
29. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases
30. Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID‐19 severity: An Italian study
31. Anti-Carbamylated Protein (Anti-CarP) Antibodies in Patients Evaluated for Suspected Rheumatoid Arthritis
32. Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19
33. Comparative analysis of different enzyme immunoassays for assessment of phosphatidylserine-dependent antiprothrombin antibodies
34. PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis
35. The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies
36. Necessity of harmonization of tissue transglutaminase IgA assays to align clinical decision making in coeliac disease
37. Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study
38. Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against β2-Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti–Domain 1 to Anti–Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome
39. Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS?
40. Chapter 6 - The evolving potential of precision medicine in the management of autoimmune liver disease
41. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk
42. High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis
43. AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC
44. IgA Anti-b2GPI Antibodies in Patients with Autoimmune Liver Diseases
45. Serum Cartilage Oligomeric Matrix Protein and Golgi Protein-73: New Diagnostic and Predictive Tools for Liver Fibrosis and Hepatocellular Cancer?
46. Diagnostic Relevance and Clinical Significance of the New Enhanced Performance M2 (MIT3) ELISA for the Detection of IgA and IgG Antimitochondrial Antibodies in Primary Biliary Cirrhosis
47. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour
48. Anti-HMGCR myopathy overlaps with dermatomyositis-like rash: a distinct subtype of idiopathic inflammatory myopathy
49. Frequency and Significance of Antibodies to Saccharomyces cerevisiae in Autoimmune Hepatitis
50. Frequency and Significance of Antibodies to Chromatin in Autoimmune Hepatitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.